Reuters: Glaxo links with university on amyloidosis drug

[NaDiNe]

Glaxo links with university on amyloidosis drug
      
   
      

LONDON (Reuters) - GlaxoSmithKline Plc said on Tuesday it had signed a deal with University College London to develop a new treatment for amyloidosis, a rare and often fatal disease that causes organ failure.<div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login